AI assistant
Sending…
Microbot Medical Inc. — Director's Dealing 2017
Sep 25, 2017
33819_dirs_2017-09-25_e5205dac-2af3-4d8d-925b-cf61cbc49b1b.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Microbot Medical Inc. (MBOT)
CIK: 0000883975
Period of Report: 2017-09-15
Reporting Person: Shoham Moshe (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2017-09-15 | Common Stock | S | 74975 | $1.25 | Disposed | 1592090 | Direct |
| 2017-09-15 | Common Stock | S | 28657 | $1.255 | Disposed | 1592090 | Direct |
| 2017-09-15 | Common Stock | S | 40500 | $1.26 | Disposed | 1592090 | Direct |
| 2017-09-15 | Common Stock | S | 20276 | $1.265 | Disposed | 1592090 | Direct |
| 2017-09-15 | Common Stock | S | 400 | $1.2675 | Disposed | 1592090 | Direct |
| 2017-09-15 | Common Stock | S | 27384 | $1.27 | Disposed | 1592090 | Direct |
| 2017-09-15 | Common Stock | S | 1200 | $1.275 | Disposed | 1592090 | Direct |
| 2017-09-15 | Common Stock | S | 14400 | $1.28 | Disposed | 1592090 | Direct |
| 2017-09-15 | Common Stock | S | 11083 | $1.285 | Disposed | 1592090 | Direct |
| 2017-09-15 | Common Stock | S | 6463 | $1.29 | Disposed | 1592090 | Direct |
| 2017-09-15 | Common Stock | S | 9001 | $1.295 | Disposed | 1592090 | Direct |
| 2017-09-15 | Common Stock | S | 6500 | $1.3 | Disposed | 1592090 | Direct |
| 2017-09-15 | Common Stock | S | 1471 | $1.305 | Disposed | 1592090 | Direct |
| 2017-09-15 | Common Stock | S | 7490 | $1.31 | Disposed | 1592090 | Direct |
| 2017-09-15 | Common Stock | S | 200 | $1.32 | Disposed | 1592090 | Direct |
Footnotes
F1: Reporting Person, through his Rule 10b5-1 trading plan, sold an aggregate of 250,000 shares of Issuer common stock on September 15, 2017. Accordingly, Reporting Person beneficially owned 1,592,090 shares of Issuer common stock following the reported transactions.
More from Microbot Medical Inc.
Regulatory Filings
2026
Jun 2
Regulatory Filings
2026
May 26
Regulatory Filings
2026
May 15
Earnings Release
2026
May 14
Interim / Quarterly Report
2026
May 13
Regulatory Filings
2026
May 5
Regulatory Filings
2026
Apr 30
Regulatory Filings
2026
Apr 22
Regulatory Filings
2026
Apr 14
Regulatory Filings
2026
Apr 13